"MIATA"-Minimal Information about T Cell Assays

Sylvia Janetzki; Cedrik M. Britten; Michael Kalos; Hyam I. Levitsky; Holden T. Maecker; Cornelius J M Melief; Lloyd J. Old; Pedro Romero; Axel Hoos; Mark M. Davis

doi:10.1016/j.immuni.2009.09.007

"MIATA"-Minimal Information about T Cell Assays

Sylvia Janetzki, Cedrik M. Britten, Michael Kalos, Hyam I. Levitsky, Holden T. Maecker, Cornelius J M Melief, Lloyd J. Old, Pedro Romero, Axel Hoos, Mark M. Davis

School of Medicine

Research output: Contribution to journal › Article › peer-review

150 Scopus citations

Abstract

Immunotherapy, especially therapeutic vaccination, has a great deal of potential in the treatment of cancer and certain infectious diseases such as HIV (Allison et al., 2006; Fauci et al., 2008; Feldmann and Steinman, 2005). Numerous vaccine candidates have been tested in patients with a variety of tumor types and chronic viral diseases. Often, the best way to assess the clinical potential of these vaccines is to monitor the induced T cell response, and yet there are currently no standards for reporting these results. This letter is an effort to address this problem.

Original language	English (US)
Pages (from-to)	527-528
Number of pages	2
Journal	Immunity
Volume	31
Issue number	4
DOIs	https://doi.org/10.1016/j.immuni.2009.09.007
State	Published - Oct 16 2009

ASJC Scopus subject areas

Immunology and Allergy
Infectious Diseases
Immunology

Access to Document

10.1016/j.immuni.2009.09.007

Cite this

@article{92c2d462daa542118d83503355436d7f,

title = "{"}MIATA{"}-Minimal Information about T Cell Assays",

abstract = "Immunotherapy, especially therapeutic vaccination, has a great deal of potential in the treatment of cancer and certain infectious diseases such as HIV (Allison et al., 2006; Fauci et al., 2008; Feldmann and Steinman, 2005). Numerous vaccine candidates have been tested in patients with a variety of tumor types and chronic viral diseases. Often, the best way to assess the clinical potential of these vaccines is to monitor the induced T cell response, and yet there are currently no standards for reporting these results. This letter is an effort to address this problem.",

author = "Sylvia Janetzki and Britten, {Cedrik M.} and Michael Kalos and Levitsky, {Hyam I.} and Maecker, {Holden T.} and Melief, {Cornelius J M} and Old, {Lloyd J.} and Pedro Romero and Axel Hoos and Davis, {Mark M.}",

year = "2009",

month = oct,

day = "16",

doi = "10.1016/j.immuni.2009.09.007",

language = "English (US)",

volume = "31",

pages = "527--528",

journal = "Immunity",

issn = "1074-7613",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - "MIATA"-Minimal Information about T Cell Assays

AU - Janetzki, Sylvia

AU - Britten, Cedrik M.

AU - Kalos, Michael

AU - Levitsky, Hyam I.

AU - Maecker, Holden T.

AU - Melief, Cornelius J M

AU - Old, Lloyd J.

AU - Romero, Pedro

AU - Hoos, Axel

AU - Davis, Mark M.

PY - 2009/10/16

Y1 - 2009/10/16

N2 - Immunotherapy, especially therapeutic vaccination, has a great deal of potential in the treatment of cancer and certain infectious diseases such as HIV (Allison et al., 2006; Fauci et al., 2008; Feldmann and Steinman, 2005). Numerous vaccine candidates have been tested in patients with a variety of tumor types and chronic viral diseases. Often, the best way to assess the clinical potential of these vaccines is to monitor the induced T cell response, and yet there are currently no standards for reporting these results. This letter is an effort to address this problem.

AB - Immunotherapy, especially therapeutic vaccination, has a great deal of potential in the treatment of cancer and certain infectious diseases such as HIV (Allison et al., 2006; Fauci et al., 2008; Feldmann and Steinman, 2005). Numerous vaccine candidates have been tested in patients with a variety of tumor types and chronic viral diseases. Often, the best way to assess the clinical potential of these vaccines is to monitor the induced T cell response, and yet there are currently no standards for reporting these results. This letter is an effort to address this problem.

UR - http://www.scopus.com/inward/record.url?scp=70349833381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349833381&partnerID=8YFLogxK

U2 - 10.1016/j.immuni.2009.09.007

DO - 10.1016/j.immuni.2009.09.007

M3 - Article

C2 - 19833080

AN - SCOPUS:70349833381

SN - 1074-7613

VL - 31

SP - 527

EP - 528

JO - Immunity

JF - Immunity

IS - 4

ER -

"MIATA"-Minimal Information about T Cell Assays

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this